|
DE150423C
(OSRAM)
|
|
|
|
|
|
DE151036C
(OSRAM)
|
|
|
|
|
|
US812554A
(en)
|
1905-11-08 |
1906-02-13 |
Hoechst Ag |
Alkamin esters of para-aminobenzoic acid.
|
|
US1889645A
(en)
|
1930-12-22 |
1932-11-29 |
Winthrop Chem Co Inc |
Beta-dimethylaminoethyl ester of para-butylamino-benzoic acid
|
|
US2441498A
(en)
|
1943-07-15 |
1948-05-11 |
Astra Apotekarnes Kem Fab |
Alkyl glycinanilides
|
|
US2689248A
(en)
|
1950-06-17 |
1954-09-14 |
Sterling Drug Inc |
Tertiary-aminoalkyl 4-amino-2-alkoxybenzoates and their synth esis
|
|
US2799679A
(en)
|
1955-04-28 |
1957-07-16 |
Bofors Ab |
Process of preparing amides of heterocyclic carboxylic acids
|
|
US2883271A
(en)
|
1956-11-23 |
1959-04-21 |
Phillips Petroleum Co |
Safety system for combustion process
|
|
US2955111A
(en)
|
1957-01-28 |
1960-10-04 |
Bofors Ab |
Synthesis of n-alkyl-piperidine and n-alkyl-pyrrolidine-alpha-carboxylic acid amides
|
|
US3160662A
(en)
|
1957-06-26 |
1964-12-08 |
Astra Apotekarnes Kem Fab |
Lower alkylaminoacyl amide anesthetics
|
|
NL281394A
(OSRAM)
|
1961-07-25 |
|
|
|
|
DE1251764B
(de)
|
1965-08-18 |
1967-10-12 |
C H Boehnnger Sohn Ingelheim/ Rhein |
Verfahren zur Herstellung von antimikrobiell wirksamen 12 3,4-Tetra hydro 9 -ammo acridmiumverbmdungen
|
|
US3812147A
(en)
|
1970-12-22 |
1974-05-21 |
Astra Pharma Prod |
Acylxylidide local anaesthetics
|
|
US3931195A
(en)
|
1971-03-03 |
1976-01-06 |
Mead Johnson & Company |
Substituted piperidines
|
|
BE786875A
(fr)
|
1971-07-28 |
1973-01-29 |
Astra Pharma Prod |
Amide, methode pour sa preparation et ses compositions therapeutiques
|
|
US3773939A
(en)
|
1971-11-24 |
1973-11-20 |
Janssen Pharmaceutica Nv |
N-arallyl-n'-aralkyl piperazine pharmaceutical compositions
|
|
US4069309A
(en)
|
1972-09-19 |
1978-01-17 |
Avon Products, Inc. |
Cationic skin substantive sunscreen composition and method
|
|
US3900481A
(en)
|
1974-04-01 |
1975-08-19 |
Riker Laboratories Inc |
Derivatives of pyrrolidine and piperidine
|
|
CS195321B2
(en)
|
1975-12-23 |
1980-01-31 |
Ciba Geigy Ag |
Plant growth suppressing agents
|
|
US4070347A
(en)
|
1976-08-16 |
1978-01-24 |
Alza Corporation |
Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality
|
|
DE2915250A1
(de)
|
1979-04-14 |
1980-10-30 |
Basf Ag |
Salze von alpha -aminoacetaniliden
|
|
US4293539A
(en)
|
1979-09-12 |
1981-10-06 |
Eli Lilly And Company |
Controlled release formulations and method of treatment
|
|
US4877805A
(en)
|
1985-07-26 |
1989-10-31 |
Kligman Albert M |
Methods for treatment of sundamaged human skin with retinoids
|
|
US4757128A
(en)
|
1986-08-01 |
1988-07-12 |
Massachusetts Institute Of Technology |
High molecular weight polyanhydride and preparation thereof
|
|
US5169637A
(en)
|
1983-03-24 |
1992-12-08 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
|
CA1237671A
(en)
|
1983-08-01 |
1988-06-07 |
Michael W. Fountain |
Enhancement of pharmaceutical activity
|
|
EP0151110B1
(en)
|
1983-08-01 |
1989-03-01 |
Astra Läkemedel Aktiebolag |
L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
|
|
US4975282A
(en)
|
1985-06-26 |
1990-12-04 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
|
US5409704A
(en)
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
US5023087A
(en)
|
1986-02-10 |
1991-06-11 |
Liposome Technology, Inc. |
Efficient method for preparation of prolonged release liposome-based drug delivery system
|
|
IE60901B1
(en)
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
|
US5049388A
(en)
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
|
DK171349B1
(da)
|
1986-11-14 |
1996-09-16 |
Hoffmann La Roche |
Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf, lægemidler indeholdende forbindelserne samt anvendelse af forbindelserne til fremstilling af lægemidler
|
|
US5032582A
(en)
|
1987-02-27 |
1991-07-16 |
Liposome Technology, Inc. |
Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
|
|
US4994213A
(en)
|
1988-05-17 |
1991-02-19 |
Liposome Technology, Inc. |
Method of preparing lipid structures
|
|
US5082866A
(en)
|
1988-06-01 |
1992-01-21 |
Odontex, Inc. |
Biodegradable absorption enhancers
|
|
US4980378A
(en)
|
1988-06-01 |
1990-12-25 |
Odontex, Inc. |
Biodegradable absorption enhancers
|
|
US5194581A
(en)
|
1989-03-09 |
1993-03-16 |
Leong Kam W |
Biodegradable poly(phosphoesters)
|
|
US5194266A
(en)
|
1989-08-08 |
1993-03-16 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition and method
|
|
US5356633A
(en)
|
1989-10-20 |
1994-10-18 |
Liposome Technology, Inc. |
Method of treatment of inflamed tissues
|
|
CA2108288C
(en)
|
1991-04-19 |
2003-09-16 |
Jill P. Adler-Moore |
Liposomal cyclosporin formulation and process for the preparation thereof
|
|
US5176907A
(en)
|
1991-08-13 |
1993-01-05 |
The Johns Hopkins University School Of Medicine |
Biocompatible and biodegradable poly (phosphoester-urethanes)
|
|
GR1002207B
(en)
|
1992-08-06 |
1996-03-27 |
Johnson & Johnson Consumer |
Skin care compositions containing imidazoles.
|
|
US5552155A
(en)
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
|
US5480971A
(en)
*
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
|
US6051576A
(en)
|
1994-01-28 |
2000-04-18 |
University Of Kentucky Research Foundation |
Means to achieve sustained release of synergistic drugs by conjugation
|
|
US5591317A
(en)
|
1994-02-16 |
1997-01-07 |
Pitts, Jr.; M. Michael |
Electrostatic device for water treatment
|
|
US5716622A
(en)
|
1995-01-06 |
1998-02-10 |
The Rockefeller University |
Functionally active regions of signal transducer and activators of transcription
|
|
US5783683A
(en)
|
1995-01-10 |
1998-07-21 |
Genta Inc. |
Antisense oligonucleotides which reduce expression of the FGFRI gene
|
|
US5747470A
(en)
|
1995-06-07 |
1998-05-05 |
Gen-Probe Incorporated |
Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA
|
|
AU5938996A
(en)
|
1995-06-07 |
1996-12-30 |
Nexstar Pharmaceuticals, Inc. |
Method for encapsulating pharmaceutical materials
|
|
US6413961B1
(en)
|
1995-12-12 |
2002-07-02 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain and inflammation
|
|
SE508357C2
(sv)
|
1996-01-02 |
1998-09-28 |
Kay Laserow |
Mätinstrument för mätning av smärta jämte ett förfarande för att med ett mätinstrument mäta smärta
|
|
WO1998024428A1
(en)
|
1996-12-02 |
1998-06-11 |
Brigham & Women's Hospital, Inc. |
Long-acting local anesthetics
|
|
SE9604751D0
(sv)
|
1996-12-20 |
1996-12-20 |
Astra Ab |
New therapy
|
|
US5837713A
(en)
*
|
1997-02-26 |
1998-11-17 |
Mayo Foundation For Medical Education And Research |
Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
|
|
WO1998058012A1
(en)
|
1997-06-18 |
1998-12-23 |
Guilford Pharmaceuticals Inc. |
Two-stage solution polymerization of high molecular weight poly(phosphoesters)
|
|
US6028163A
(en)
|
1997-06-27 |
2000-02-22 |
Guilford Pharmaceuticals Inc. |
Solution polymerization of high molecular weight poly(phosphoesters) in toluene
|
|
ATE320249T1
(de)
|
1997-07-08 |
2006-04-15 |
Ono Pharmaceutical Co |
Aminosäurederivate
|
|
US6623040B1
(en)
|
1997-09-03 |
2003-09-23 |
Recot, Inc. |
Method for determining forced choice consumer preferences by hedonic testing
|
|
TW536401B
(en)
|
1997-09-03 |
2003-06-11 |
Cardiome Pharma Corp |
A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain
|
|
US6083996A
(en)
|
1997-11-05 |
2000-07-04 |
Nexmed Holdings, Inc. |
Topical compositions for NSAI drug delivery
|
|
US6362197B1
(en)
|
1998-06-09 |
2002-03-26 |
Cardiome Pharma Corp. |
Compositions and method for treatment of cough
|
|
US6153212A
(en)
|
1998-10-02 |
2000-11-28 |
Guilford Pharmaceuticals Inc. |
Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
|
|
US6103255A
(en)
|
1999-04-16 |
2000-08-15 |
Rutgers, The State University |
Porous polymer scaffolds for tissue engineering
|
|
US6118020A
(en)
|
1999-05-19 |
2000-09-12 |
Nexmed Holdings, Inc. |
Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
|
|
EP1216243A1
(en)
*
|
1999-10-01 |
2002-06-26 |
Advanced Medicine, Inc. |
Quinazolinones and analogues and their use as local anesthetics
|
|
PL355904A1
(en)
|
1999-12-15 |
2004-05-31 |
Usb Farchim S.A. |
Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
|
|
AU2334501A
(en)
*
|
1999-12-15 |
2001-06-25 |
Ucb Farchim Sa |
Cyclic quaternary ammonium compounds
|
|
WO2001045678A2
(de)
|
1999-12-21 |
2001-06-28 |
Id Pharma Gmbh |
Arzneimittel, verfahren zu dessen herstellung und dessen verwendung
|
|
AU2001259561A1
(en)
|
2000-05-04 |
2001-11-12 |
Dzgenes, L.L.C. |
Tgfbeta-rii promoter polymorphisms
|
|
MXPA03000188A
(es)
*
|
2000-06-23 |
2003-09-22 |
Mayo Foundation |
Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
|
|
DE10039449A1
(de)
|
2000-08-11 |
2003-07-24 |
Id Pharma Gmbh I Ins |
Verwendung einer lokalanästhetikumhaltigen Zusammensetzung zur Behandlung von Hyperalgesien
|
|
US6766319B1
(en)
|
2000-10-31 |
2004-07-20 |
Robert J. Might |
Method and apparatus for gathering and evaluating information
|
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
|
WO2002058670A1
(en)
|
2001-01-25 |
2002-08-01 |
Euroceltique S.A. |
Local anesthetic, and method of use
|
|
US20040146590A1
(en)
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
|
US20030027833A1
(en)
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
CA2450769A1
(en)
|
2001-06-15 |
2002-12-27 |
Vertex Pharmaceuticals Incorporated |
5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
|
|
ITMI20012025A1
(it)
|
2001-09-28 |
2003-03-28 |
Dompe Spa |
Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
|
|
DK1534320T3
(da)
|
2002-08-02 |
2007-04-02 |
Univ Bruxelles |
Apolipoprotein L-I til behandling af trypanosomen sygdomme
|
|
EP2907503A1
(en)
|
2003-04-10 |
2015-08-19 |
Neurogesx, Inc. |
Methods and compositions for administration of TRPV1 agonists
|
|
US20060135506A1
(en)
|
2003-04-22 |
2006-06-22 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
|
|
US20040220187A1
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of pain, inflammation or inflammation mediated disorders
|
|
ES2223277B1
(es)
|
2003-06-19 |
2006-03-01 |
Fernando Bouffard Fita |
Composicion anestesica para administracion topica.
|
|
US8361467B2
(en)
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
|
NO20034069L
(no)
|
2003-09-12 |
2005-03-14 |
Aximed As |
Fremstilling og bruk av capsaicinderivater
|
|
US20070149469A1
(en)
|
2003-10-02 |
2007-06-28 |
Christian Korherr |
Medical use of tbk-1 or of inhibitors thereof
|
|
US20050142596A1
(en)
|
2003-11-14 |
2005-06-30 |
Krolewski Andrzej S. |
Methods of diagnosing renal and cardiovascular disease
|
|
CN1894215B
(zh)
|
2003-12-11 |
2012-03-21 |
得克萨斯州大学系统董事会 |
治疗细胞增殖疾病的化合物
|
|
US20070196866A1
(en)
|
2004-03-13 |
2007-08-23 |
Irm Llc |
Modulators of ion channel trpa1
|
|
US7161034B2
(en)
|
2004-04-20 |
2007-01-09 |
Dade Behring Inc. |
Lidocaine analogs and methods of making and using same
|
|
WO2005105814A1
(en)
|
2004-04-28 |
2005-11-10 |
Incyte Corporation |
Tetracyclic inhibitors of janus kinases
|
|
CA2569155A1
(en)
|
2004-06-02 |
2005-12-15 |
Sri International |
Formulations comprising a capsaicinoid a local anesthetic and/or an antipruritic agent for the treatment of pain
|
|
PT1781272T
(pt)
|
2004-07-24 |
2017-12-11 |
Esteve Labor Dr |
Utilização de compostos ativos no recetor sigma para o tratamento de alodinia mecânica
|
|
ITMI20041566A1
(it)
|
2004-07-30 |
2004-10-30 |
Indena Spa |
"trpv1 agonisti, formulazioni che li contengono e loro usi"
|
|
AU2005290312A1
(en)
*
|
2004-09-20 |
2006-04-06 |
Corus Pharma, Inc. |
Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
|
|
US7947682B2
(en)
|
2004-12-29 |
2011-05-24 |
University Of Southern California |
Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents
|
|
AU2005316687B2
(en)
|
2004-12-16 |
2008-06-26 |
Alkermes, Inc. |
Compositions and methods for pulmonary conditions
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
CA2621261C
(en)
|
2005-09-22 |
2014-05-20 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
|
EP2341059A1
(en)
|
2005-10-12 |
2011-07-06 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
DK3184526T3
(en)
|
2005-12-13 |
2019-01-14 |
Incyte Holdings Corp |
PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR
|
|
US20070197509A1
(en)
|
2005-12-21 |
2007-08-23 |
Painceptor Pharma Corporation |
Compositions and methods for modulating gated ion channels
|
|
GB0526244D0
(en)
*
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
EP1867338A1
(en)
|
2006-05-30 |
2007-12-19 |
Université Libre De Bruxelles |
Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases
|
|
CA2668652C
(en)
*
|
2006-11-20 |
2018-06-12 |
President And Fellows Of Harvard College |
Inhibitors of voltage-gated ion channels for use in treating pain and pruritis
|
|
EP2121692B1
(en)
|
2006-12-22 |
2013-04-10 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
|
WO2009026107A1
(en)
|
2007-08-17 |
2009-02-26 |
Portola Pharmaceuticals, Inc. |
Protein kinase inhibitors
|
|
CN101156851A
(zh)
*
|
2007-09-27 |
2008-04-09 |
刘全胜 |
盐酸尼卡地平分散片及其制备方法
|
|
JP2011513484A
(ja)
*
|
2008-03-11 |
2011-04-28 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
疼痛および掻痒症を治療するための方法、組成物、およびキット
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
NZ588830A
(en)
|
2008-04-22 |
2012-11-30 |
Portola Pharm Inc |
Inhibitors of protein kinases
|
|
WO2010005807A2
(en)
|
2008-07-08 |
2010-01-14 |
Board Of Regents, The University Of Texas System |
Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats)
|
|
DE102008037682A1
(de)
*
|
2008-08-14 |
2010-04-08 |
Strackharn, Klaus, Dr.med. |
Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
|
|
CN101347427A
(zh)
*
|
2008-09-22 |
2009-01-21 |
北京理工大学 |
一种沙坦化合物或其可药用盐和钙通道阻断剂或可药用盐的复方
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
EP2349271A2
(en)
|
2008-10-06 |
2011-08-03 |
Idera Pharmaceuticals, Inc. |
Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
|
|
EP2411019A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
JP6205133B2
(ja)
|
2009-07-10 |
2017-09-27 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
|
|
US9023355B2
(en)
|
2010-04-13 |
2015-05-05 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions and methods for treating renal disease
|
|
US9828637B2
(en)
|
2010-04-18 |
2017-11-28 |
Wake Forest University Health Sciences |
Methods of predicting predisposition to or risk of kidney disease
|
|
EP2611448A1
(en)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
|
US8822537B2
(en)
|
2012-09-27 |
2014-09-02 |
Achelios Therapeutics, Inc. |
Topical ketoprofen composition
|
|
JP6833811B2
(ja)
|
2015-08-03 |
2021-02-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
荷電イオンチャネル遮断薬及び使用方法
|